Skip to main content

Table 2 Univariable analysis of clinical and CMR characteristics for prediction of adverse events

From: Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing

 

MACE

Cardiovascular mortality

Hazard ratio (95% CI)

p value

Hazard ratio (95% CI)

p value

Age

1.04 (1.02–1.05)

< 0.001

1.06 (1.04–1.08)

< 0.001

Male

1.56 (1.14–2.14)

0.006

1.77 (1.21–2.60)

0.003

BMI

1.04 (0.98–1.09)

0.123

0.96 (0.90–1.03)

0.282

Hypertension

1.22 (1.03–1.60)

0.033

1.18 (0.97–1.57)

0.077

Diabetes mellitus

1.35 (1.04–1.77)

0.041

1.59 (1.14–2.23)

0.006

Dyslipidemia

1.41 (1.05–1.89)

0.022

1.55 (1.09–2.20)

0.014

Smoking

1.02 (0.77–1.36)

0.757

1.03 (0.79–1.40)

0.675

Family history of CAD

1.01 (0.74–1.38)

0.937

1.05 (0.73–1.50)

0.810

Known CAD

1.30 (1.01–1.69)

0.043

1.21 (0.93–1.71)

0.122

Known MI

0.80 (0.57–1.15)

0.222

0.82 (0.53–1.26)

0.361

Peripheral atheroma

1.35 (0.84–2.17)

0.212

1.59 (0.94–2.67)

0.082

Ischemic stroke

1.03 (0.53–2.01)

0.936

0.90 (0.39–2.03)

0.793

History of hospitalization for HF

1.35 (0.69–2.64)

0.376

1.48 (0.69–3.17)

0.311

Symptomatic angina

1.63 (0.83–3.22)

0.16

0.92 (0.50–1.71)

0.88

Dyspnea

0.91 (0.47–1.73)

0.77

0.78 (0.47–1.30)

0.35

Ten-year risk for fatal CAD (modified SCORE project)

1.22 (1.08–1.80)

< 0.001

1.29 (1.10–1.83)

< 0.001

Presence of inducible ischemia

2.88 (2.18–3.81)

< 0.001

2.44 (1.75–3.40)

< 0.001

Number of segments of inducible ischemia

1.61 (1.51–1.72)

< 0.001

1.55 (1.43–1.67)

< 0.001

Presence of LGE

1.46 (1.16–1.89)

< 0.001

1.38 (1.06–1.77)

0.031

Number of segments of LGE

1.40 (1.30–1.52)

< 0.001

1.33 (1.21–1.45)

< 0.001

LVEFa

0.85 (0.79–0.91)

< 0.001

0.92 (0.84–0.98)

0.024

LV end-diastolic volume indexa

1.07 (1.04–1.10)

< 0.001

1.03 (0.90–1.37)

0.315

LV end-systolic volume indexa

1.09 (1.05–1.12)

< 0.001

1.05 (0.92–1.42)

0.221

RV ejection fraction

0.99 (0.80–1.23)

0.45

1.09 (0.81–1.52)

0.72

CMR-related coronary revascularization

2.43 (1.83–3.22)

< 0.001

2.04 (1.46–2.86)

< 0.001

  1. Bold empasis means that the P value has reached statistical significance, with 2-tailed P value < 0.05
  2. BMI body mass index, CAD coronary artery disease, CI confidence interval, CMR cardiac magnetic resonance, HF heart failure, LGE late gadolinium enhancement, LV left ventricle, LVEF left ventricular ejection fraction, MACE major adverse cardiac events, MI myocardial infarction, RV right ventricle
  3. aIncrement of 10 units
  4. bDefined by a coronary revascularisation performed within 90 days after the stress CMR examination